Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2
The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
RNA editing by site-selective deamination of adenosine to inosine alters codons and splicing in nuclear transcripts, and therefore protein function. ADAR2 (refs 7, 8) is a candidate mammalian editing enzyme that is widely expressed in brain and other tissues, but its RNA substrates are unknown. Here we have studied ADAR2-mediated RNA editing by generating mice that are homozygous for a targeted functional null allele. Editing in ADAR2-/- mice was substantially reduced at most of 25 positions in diverse transcripts; the mutant mice became prone to seizures and died young. The impaired phenotype appeared to result entirely from a single underedited position, as it reverted to normal when both alleles for the underedited transcript were substituted with alleles encoding the edited version exonically. The critical position specifies an ion channel determinant, the Q/R site, in AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate) receptor GluR-B pre-messenger RNA. We conclude that this transcript is the physiologically most important substrate of ADAR2.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several mis-sense RDDs in the AMPA receptor are edited at specific stages of human brain development78 and are required for normal brain function and phenotype in mice79.”
From Decoding neuroproteomics: integrating the genome, translatome and functional anatomy (2014) · cites this paper as [79]
Citations
Cites
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,640
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329
Geiger, J. R. P., Melcher, T., Koh, D.-S., Sakmann, B., Seeburg, P. H., Jonas, P., & Monyer, H. (1995) · Neuron · doi:10.1016/0896-6273(95)90076-4 · Cited by 1,260
Self-citationRegulation of serotonin-2C receptor G-protein coupling by RNA editing
Burns, C. M., Chu, H., Rueter, S. M., Hutchinson, L. K., Canton, H., Sanders-Bush, E., & Emeson, R. B. (1997) · Nature · doi:10.1038/387303a0 · Cited by 1,010
Importance of AMPA Receptors for Hippocampal Synaptic Plasticity But Not for Spatial Learning
Zamanillo, D., Sprengel, R., Hvalby, Ø., Jensen, V., Burnashev, N., Rozov, A., Kaiser, K. M. M., Köster, H. J., Borchardt, T., Worley, P., et al. (1999) · Science · doi:10.1126/science.284.5421.1805 · Cited by 791 · cited 1×
“Notably, mice lacking all GluR-A expression are phenotypically robust and normal in most respect”
BackgroundSelf-citationControl of Kinetic Properties of AMPA Receptor Channels by Nuclear RNA Editing
Lomeli, H., Mosbacher, J., Melcher, T., Höger, T., Geiger, J. R. P., Kuner, T., Monyer, H., Higuchi, M., Bach, A., & Seeburg, P. H. (1994) · Science · doi:10.1126/science.7992055 · Cited by 746
Self-citationHiguchi, M., Single, F. N., Köhler, M., Sommer, B., Sprengel, R., & Seeburg, P. H. (1993) · Cell · doi:10.1016/0092-8674(93)90622-w · Cited by 662
Self-citationRegulation of alternative splicing by RNA editing
Rueter, S. M., Dawson, T. R., & Emeson, R. B. (1999) · Nature · doi:10.1038/19992 · Cited by 637
Modification and Editing of RNA
(1998) · ASM Press eBooks · doi:10.1128/9781555818296 · Cited by 636
Brusa, R., Zimmermann, F., Koh, D.-S., Feldmeyer, D., Gass, P., Seeburg, P. H., & Sprengel, R. (1995) · Science · doi:10.1126/science.270.5242.1677 · Cited by 592
Self-citation
Research works printed but not linked: 1
- Wisden, W. & Morris, B. J. in In Situ Protocols for the Brain (eds Wisden, W. & Morris, B. J. 9–30 (Academic, London, 1994).
Cited by
Items 401–500 of 1,000
Slavov, D. B., & Gardiner, K. (2002) · Gene · doi:10.1016/s0378-1119(02)01016-8 · Cited by 44
Ganem, N. S., Ben-Asher, N., Manning, A. C., Deffit, S. N., Washburn, M. C., Wheeler, E. C., Yeo, G. W.-M., Zgayer, O. B.-N., Mantsur, E., Hundley, H. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.095 · Cited by 44
Macbeth, M. R., & Bass, B. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)24015-7 · Cited by 43
A method to find tissue-specific novel sites of selective adenosine deamination
Ohlson, J. I., Ensterö, M., Sjöberg, B.-M., & Öhman, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni169 · Cited by 43
Is there any sense in antisense editing?
Neeman, Y., Dahary, D., Levanon, E. Y., Sorek, R., & Eisenberg, E. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.08.005 · Cited by 43
A mark of disease: how mRNA modifications shape genetic and acquired pathologies
Destefanis, E., Avşar, G., Groza, P., Romitelli, A., Torrini, S., Pir, P., Conticello, S. G., Aguiló, F., & Dassi, E. (2020) · RNA · doi:10.1261/rna.077271.120 · Cited by 42
Kawahara, Y., Ito, K., Ito, M., Tsuji, S., & Kwak, S. (2005) · Gene · doi:10.1016/j.gene.2005.07.028 · Cited by 42
Conserved responses to oxygen deprivation
O’Farrell, P. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12562 · Cited by 42
Spatio-temporal regulation of ADAR editing during development in porcine neural tissues
Venø, M. T., Bramsen, J. B., Bendixen, C., Panitz, F., Holm, I. E., Öhman, M., & Kjems, J. (2012) · RNA Biology · doi:10.4161/rna.21082 · Cited by 42
Marshall, P. R., Zhao, Q., Li, X., Wei, W., Periyakaruppiah, A., Zajaczkowski, E. L., Leighton, L. J., Madugalle, S. U., Basic, D., Wang, Z., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0627-5 · Cited by 42
Substitutional A‐to‐I RNA editing
Wulff, B., & Nishikura, K. (2010) · WIREs RNA · doi:10.1002/wrna.10 · Cited by 41
Herbrechter, R., Hube, N., Buchholz, R., & Reiner, A. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03865-z · Cited by 41
Colombrita, C., Onesto, E., Tiloca, C., Ticozzi, N., Silani, V., & Ratti, A. (2011) · PubMed · doi:10.4449/aib.v149i1.1261 · Cited by 41
CAPS1 RNA Editing Promotes Dense Core Vesicle Exocytosis
Miyake, K., Ohta, T., Nakayama, H., Doe, N., Terao, Y., Oiki, E., Nagatomo, I., Yamashita, Y., Abe, T., Nishikura, K., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.073 · Cited by 41
Yang, Y., Lv, J., Gui, B., Yin, H., Wu, X., Zhang, Y., & Jin, Y. (2008) · RNA · doi:10.1261/rna.1063708 · Cited by 41
Mahajan, S. S., Thai, K. H., Chen, K., & Ziff, E. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.027 · Cited by 40
Zaidan, H., Ramaswami, G., Golumbic, Y. N., Sher, N., Malik, A., Barak, M., Galiani, D., Dekel, N., Li, J. B., & Gaisler‐Salomon, I. (2018) · BMC Genomics · doi:10.1186/s12864-017-4409-8 · Cited by 40
The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance
Wood, S., Willbanks, A. R., & Cheng, J. X. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009621666210127092828 · Cited by 40
Posttranscriptional recoding by RNA editing
Maas, S. (2012) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-386497-0.00006-2 · Cited by 40
Self-citationRNA editing signature during myeloid leukemia cell differentiation
Rossetti, C., Picardi, E., Ye, M., Camilli, G., D’Erchia, A. M., Cucina, L., Locatelli, F., Fianchi, L., Teofili, L., Pesole, G., et al. (2017) · Leukemia · doi:10.1038/leu.2017.134 · Cited by 40
Streit, A. K., Derst, C., Wegner, S., Heinemann, U., Zahn, R., & Decher, N. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.02986.x · Cited by 40
Activity-Dependent A-to-I RNA Editing in Rat Cortical Neurons
Sanjana, N. E., Levanon, E. Y., Hueske, E. A., Ambrose, J. M., & Li, J. B. (2012) · Genetics · doi:10.1534/genetics.112.141200 · Cited by 39
Guo, X., Liu, S., Sheng, Y., Zenati, M., Billiar, T. R., Herbert, A. G., & Wang, Q. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112733 · Cited by 39
RNA Editing of Neurotransmitter Receptors in the Mammalian Brain
Schmauss, C., & Howe, J. R. (2002) · Science Signaling · doi:10.1126/stke.2002.133.pe26 · Cited by 39
Visualizing adenosine-to-inosine RNA editing in single mammalian cells
Mellis, I. A., Gupte, R. K., Raj, A., & Rouhanifard, S. H. (2017) · Nature Methods · doi:10.1038/nmeth.4332 · Cited by 39
Sequence based identification of RNA editing sites
Eisenberg, E., Li, J. B., & Levanon, E. Y. (2010) · RNA Biology · doi:10.4161/rna.7.2.11565 · Cited by 39
Irimia, M., Denuc, A., Ferran, J. L., Pernaute, B., Puelles, L., Roy, S. W., Garcia-Fernàndez, J., & Marfany, G. (2012) · RNA Biology · doi:10.4161/rna.9.1.18387 · Cited by 38
The emerging role of RNA and DNA editing in cancer
Avesson, L., & Barry, G. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.03.001 · Cited by 38
The dynamic epitranscriptome: A to I editing modulates genetic information
Tajaddod, M., Jantsch, M. F., & Licht, K. (2015) · Chromosoma · doi:10.1007/s00412-015-0526-9 · Cited by 38
An Emerging Role for isomiRs and the microRNA Epitranscriptome in Neovascularization
van der Kwast, R. V. C. T., Quax, P. H. A., & Nossent, A. Y. (2019) · Cells · doi:10.3390/cells9010061 · Cited by 38
Effect of glutamate receptor antagonists on migrating neural progenitor cells
Jansson, L. C., Louhivuori, L. M., Wigren, H., Nordström, T., Louhivuori, V., Castrén, M. L., & Åkerman, K. E. O. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12152 · Cited by 38
Inosine-Mediated Modulation of RNA Sensing by Toll-Like Receptor 7 (TLR7) and TLR8
Sarvestani, S. T., Tate, M. D., Moffat, J. M., Jacobi, A. M., Behlke, M. A., Miller, A., Beckham, S. A., McCoy, C. E., Chen, W., Mintern, J. D., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01571-13 · Cited by 38
Editing inducer elements increases A-to-I editing efficiency in the mammalian transcriptome
Daniel, C., Widmark, A., Rigardt, D., & Öhman, M. (2017) · Genome biology · doi:10.1186/s13059-017-1324-x · Cited by 38
The effects of RNA editing in cancer tissue at different stages in carcinogenesis
Kurkowiak, M., Arcimowicz, Ł., Chruściel, E., Urban‐Wójciuk, Z., Papak, I., Keegan, L. P., O’Connell, M. A., Kowalski, J., Hupp, T. R., & Marek-Trzonkowska, N. M. (2021) · RNA Biology · doi:10.1080/15476286.2021.1877024 · Cited by 38
Yuan, J., Li, X., Bao, H., Wang, J.-L., Zhao, Y., & Chen, S. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02727-9 · Cited by 38
APOBEC1 complementation factor (A1CF) is dispensable for C-to-U RNA editing in vivo
Snyder, E. M., McCarty, C., Mehalow, A., Svenson, K. L., Murray, S. A., Korstanje, R., & Braun, R. E. (2017) · RNA · doi:10.1261/rna.058818.116 · Cited by 38
A structural determinant required for RNA editing
Tian, N., Yang, Y., Sachsenmaier, N., Muggenhumer, D., Bi, J., Waldsich, C., Jantsch, M. F., & Jin, Y. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr144 · Cited by 38
Bar-Yaacov, D. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010250 · Cited by 37
In situ hybridization with oligonucleotide probes
Wisden, W., & Morris, B. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)47051-1 · Cited by 37
The Good and the Bad of Glutamate Receptor RNA Editing
Filippini, A., Bonini, D., Via, L. L., & Barbon, A. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0201-z · Cited by 37
Regulation of Serotonin 2C Receptor Pre-mRNA Editing by Serotonin
Schmauss, C. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)63004-8 · Cited by 37
Abbas, A. I., Urban, D. J., Jensen, N., Farrell, M. S., Kroeze, W. K., Mieczkowski, P. A., Wang, Z., & Roth, B. L. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq107 · Cited by 37
The role of RNA editing by ADAR1 in prevention of innate immune sensing of self-RNA
Heraud-Farlow, J. E., & Walkley, C. R. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1416-1 · Cited by 37
Adar is essential for optimal presynaptic function
Maldonado‐Díaz, C., Alicea, D. A., Gonzalez, M., Bykhovskaia, M., & Marie, B. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.10.009 · Cited by 37
The RNA editing enzymes ADARs: mechanism of action and human disease
Tomaselli, S., Locatelli, F., & Gallo, A. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1863-3 · Cited by 37
Greenberger, S., Levanon, E. Y., Paz-Yaacov, N., Barzilai, A., Safran, M., Osenberg, S., Amariglio, N., Rechavi, G., & Eisenberg, E. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-608 · Cited by 37
Aging through an epitranscriptomic lens
McMahon, M. E., Forester, C. M., & Buffenstein, R. (2021) · Nature Aging · doi:10.1038/s43587-021-00058-y · Cited by 36
Huettner, J. E. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.272724 · Cited by 36
Kainate and AMPA receptors in epilepsy: Cell biology, signalling pathways and possible crosstalk
Henley, J. M., Nair, J. D., Seager, R., Yucel, B. P., Woodhall, G. L., Henley, B. S., Talandyte, K., Needs, H. I., & Wilkinson, K. A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108569 · Cited by 36
Evolutionary driving forces of A‐to‐I editing in metazoans
Duan, Y., Tang, X., & Lü, J. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1666 · Cited by 36
A-to-I pre-mRNA editing of the serotonin 2C receptor: Comparisons among inbred mouse strains
Du, Y., Davisson, M. T., Kafadar, K., & Gardiner, K. (2006) · Gene · doi:10.1016/j.gene.2006.06.007 · Cited by 36
ADAR Family Proteins: A Structural Review
Ashley, C. N., Broni, E., & Miller, W. A. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050243 · Cited by 36
ADAR Editing Wobbles the MicroRNA World
Das, A., & Carmichael, G. (2007) · ACS Chemical Biology · doi:10.1021/cb700064h · Cited by 36
Evolutionary and ontogenetic changes in RNA editing in human, chimpanzee, and macaque brains
Li, Z., Bammann, H., Li, M., Liang, H., Zheng, Y., Chen, Y. P., Zhao, M., & Khaitovich, P. (2013) · RNA · doi:10.1261/rna.039206.113 · Cited by 35
Ensterö, M., Åkerborg, Ö., Lundin, D., Wang, B., Furey, T. S., Öhman, M., & Lagergren, J. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-6 · Cited by 35
A Phenotypic Screen for Functional Mutants of Human Adenosine Deaminase Acting on RNA 1
Wang, Y., Havel, J., & Beal, P. A. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00711 · Cited by 35
A to I editing in disease is not fake news
Bajad, P., Jantsch, M. F., Keegan, L. P., & O’Connell, M. A. (2017) · RNA Biology · doi:10.1080/15476286.2017.1306173 · Cited by 35
Goncharov, A. O., Shender, V. О., Kuznetsova, K. G., Kliuchnikova, A. A., & Moshkovskii, S. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095240 · Cited by 34
The phenotype of the most common human ADAR1p150 Zα mutation P193A in mice is partially penetrant
Liang, Z., Chalk, A. M., Taylor, S., Goradia, A., Heraud-Farlow, J. E., & Walkley, C. R. (2023) · EMBO Reports · doi:10.15252/embr.202255835 · Cited by 34
Karagianni, K., Pettas, S., Christoforidou, G., Kanata, Ε., Bekas, N., Xanthopoulos, K., Dafou, D., & Sklaviadis, T. (2022) · Biomolecules · doi:10.3390/biom12030465 · Cited by 34
Evidence for transcriptome-wide RNA editing among Sus scrofa PRE-1 SINE elements
Funkhouser, S. A., Steibel, J. P., Bates, R. O., Raney, N. E., Schenk, D., & Ernst, C. W. (2017) · BMC Genomics · doi:10.1186/s12864-017-3766-7 · Cited by 34
A‐to‐I RNA editing of Filamin A regulates cellular adhesion, migration and mechanical properties
Jain, M. K., Weber, A., Maly, K., Manjaly, G., Deek, J., Tsvyetkova, O., Stulić, M., Toca-Herrera, J. L., & Jantsch, M. F. (2022) · FEBS Journal · doi:10.1111/febs.16391 · Cited by 34
A novel tissue-specific alternatively spliced form of the A-to-I RNA editing enzyme ADAR2
Agranat-Tamir, L., Sperling, J. M., & Sperling, R. (2010) · RNA Biology · doi:10.4161/rna.7.2.11568 · Cited by 33
High-Throughput Screening for Functional Adenosine to Inosine RNA Editing Systems
Pokharel, S., & Beal, P. A. (2006) · ACS Chemical Biology · doi:10.1021/cb6003838 · Cited by 33
Guo, X., Steinman, R. A., Sheng, Y., Cao, G., Wiley, C. A., & Wang, Q. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02646-0 · Cited by 33
Effects of Aicardi-Goutières syndrome mutations predicted from ADAR-RNA structures
Fisher, A. J., & Beal, P. A. (2017) · RNA Biology · doi:10.1080/15476286.2016.1267097 · Cited by 33
Modulation of ADAR mRNA expression in patients with congenital heart defects
Altaf, F., Vesely, C., Sheikh, A. M., Munir, R., Shah, S. T. A., & Tariq, A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0200968 · Cited by 33
RNA Editing: Unexplored Opportunities in the Cardiovascular System
Uchida, S., & Jones, S. P. (2018) · Circulation Research · doi:10.1161/circresaha.117.312512 · Cited by 33
SRSF9 selectively represses ADAR2-mediated editing of brain-specific sites in primates
Shanmugam, R., Zhang, F., Srinivasan, H., Richard, J. L. C., Liu, K. I., Zhang, X., Woo, A., Chua, Z. H. M., Buschdorf, J. P., Meaney, M. J., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky615 · Cited by 32
Tissue-selective restriction of RNA editing of CaV1.3 by splicing factor SRSF9
Huang, H. Y., Kapeli, K., Jin, W., Wong, Y. P., Arumugam, T. V., Koh, J. H., Srimasorn, S., Mallilankaraman, K. B., Chua, J. J. E., Yeo, G. W.-M., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky348 · Cited by 32
Dawn of Epitranscriptomic Medicine
Gatsiou, A., & Stellos, K. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.001927 · Cited by 32
Significance of A-to-I RNA editing of transcripts modulating pharmacokinetics and pharmacodynamics
Nakano, M., & Nakajima, M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.07.003 · Cited by 32
ADAR RNA editing in innate immune response phasing, in circadian clocks and in sleep
Sinigaglia, K., Wiatrek, D. M., Khan, A., Michalík, D., Sambrani, N., Sedmík, J., Vukić, D., O’Connell, M. A., & Keegan, L. P. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.10.011 · Cited by 32
Dynamic regulation of RNA editing of ion channels and receptors in the mammalian nervous system
Tan, B. Z., Huang, H. Y., Lam, R. A., & Soong, T. W. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-13 · Cited by 32
Belur, N. R., Bustos, B. I., Lubbe, S. J., & Mazzulli, J. R. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.003 · Cited by 31
Dynamic 5-HT2C Receptor Editing in a Mouse Model of Obesity
Schellekens, H., Clarke, G., Jeffery, I. B., Dinan, T. G., & Cryan, J. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032266 · Cited by 31
Barbon, A., Fumagalli, F., Via, L. L., Caracciolo, L., Racagni, G., Riva, M. A., & Barlati, S. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.009 · Cited by 31
Hideyama, T., Teramoto, S., Hachiga, K., Yamashita, T., & Kwak, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043469 · Cited by 31
The ADAR RNA editing enzyme controls neuronal excitability in Drosophila melanogaster
Li, X., Overton, I. M., Baines, R. A., Keegan, L. P., & O'Connell, M. A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt909 · Cited by 31
Genetic insights into migraine and glutamate: a protagonist driving the headache
Gasparini, C., Smith, R. A., & Griffiths, L. R. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.06.016 · Cited by 31
Leonardi, A., Evke, S., Lee, M., Melendez, J. A., & Begley, T. J. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.08.030 · Cited by 31
Regulation of RNA editing by intracellular acidification
Malik, T. N., Doherty, E., Gaded, V., Hill, T. M., Beal, P. A., & Emeson, R. B. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab157 · Cited by 31
Piller, M., Werkman, I. L., Brown, R. I., Latimer, A. J., & Kucenas, S. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2562-20.2021 · Cited by 31
RNA Editing—Systemic Relevance and Clue to Disease Mechanisms?
Meier, J. C., Kankowski, S., Krestel, H. E., & Hetsch, F. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00124 · Cited by 31
Penn, A. C., Balík, A., & Greger, I. H. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1044 · Cited by 30
Maroofian, R., Sedmík, J., Mazaheri, N., Scala, M., Zaki, M. S., Keegan, L. P., Malamiri, R. A., Issa, M. Y., Shariati, G., Sedaghat, A., et al. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107048 · Cited by 30
Hosaka, T., Tsuji, H., & Kwak, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010958 · Cited by 30
Literature review of baseline information to support the risk assessment of RNAi‐based GM plants
Pačes, J., Nič, M., Novotny, T., & Svoboda, P. (2017) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2017.en-1246 · Cited by 30
Matching Active Site and Substrate Structures for an RNA Editing Reaction
Pokharel, S., Jayalath, P., Maydanovych, O., Goodman, R. A., Wang, S. C., Tantillo, D. J., & Beal, P. A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9034076 · Cited by 30
Lee, S., Yang, G., Yong, Y., Liu, Y., Zhao, L., Xu, J., Zhang, X., Wan, Y., Feng, C., Fan, Z., et al. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-54 · Cited by 30
Newly identified ADAR-mediated A-to-I editing positions as a tool for ALS research
Kwak, S., Nishimoto, Y., & Yamashita, T. (2008) · RNA Biology · doi:10.4161/rna.6925 · Cited by 30
Proteome Diversification by RNA Editing
Eisenberg, E. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0787-9_14 · Cited by 30
ADAR2 enzymes: efficient site-specific RNA editors with gene therapy aspirations
Hajji, K., Sedmík, J., Cherian, A., Amoruso, D., Keegan, L. P., & O’Connell, M. A. (2022) · RNA · doi:10.1261/rna.079266.122 · Cited by 30
Raabe, C. A., Voss, R., Kummerfeld, D.-M., Brosius, J., Galiveti, C. R., Wolters, A., Seggewiss, J., Huge, A., Skryabin, B. V., & Rozhdestvensky, T. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-39940-6 · Cited by 29
Mizrahi, R. A., Schirle, N. T., & Beal, P. A. (2013) · ACS Chemical Biology · doi:10.1021/cb300692k · Cited by 29
Bonini, D., Filippini, A., Via, L. L., Fiorentini, C., Fumagalli, F., Colombi, M., & Barbon, A. (2015) · RNA Biology · doi:10.1080/15476286.2015.1008365 · Cited by 29
Wen, W., Lin, C.-Y., & Niu, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-13233-2 · Cited by 29
Cell death cascade and molecular therapy in ADAR2-deficient motor neurons of ALS
Yamashita, T., & Kwak, S. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.06.004 · Cited by 29
Diegelmann, S., Nieratschker, V., Werner, U., Hoppe, J., Zars, T. D., & Buchner, E. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-76 · Cited by 29
RNA-Guided Adenosine Deaminases: Advances and Challenges for Therapeutic RNA Editing
Chen, G., Katrekar, D., & Mali, P. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00046 · Cited by 29
Metadata
- Authors
- Higuchi, M., Maas, S., Single, F. N., Hartner, J., Rozov, A., Burnashev, N., Feldmeyer, D., Sprengel, R., & Seeburg, P. H.
- Affiliations
- Max Planck Society (DE)
- Corresponding author
- Seeburg, Peter H.
- Venue
- Nature
- Published
- 2000-07
- Volume
- 406
- Issue
- 6791
- Pages
- 78-81
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2046641567
- Cited by
- 967
- References
- 28
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 45 · 2023: 47 · 2022: 48 · 2021: 45 · 2020: 56 · 2019: 39 · 2018: 40 · 2017: 52 · 2016: 31 · 2015: 37 · 2014: 36 · 2013: 34 · 2012: 53
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Bristol-Myers Squibb Foundation
- Bristol-Myers Squibb
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- ADAR2, RNA editing, AMPA receptors, GluR-B, point mutations, seizures, lethality, null alleles
- MeSH terms
- Adenosine Deaminase, Animals, Binding Sites, Cell Nucleus, Mice, Inbred C57BL, RNA, Messenger, Seizures, RNA-Binding Proteins, Point Mutation, RNA Editing, Receptors, AMPA, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.